Andrea Kocsis

830 total citations
22 papers, 603 citations indexed

About

Andrea Kocsis is a scholar working on Immunology, Genetics and Molecular Biology. According to data from OpenAlex, Andrea Kocsis has authored 22 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 7 papers in Genetics and 5 papers in Molecular Biology. Recurrent topics in Andrea Kocsis's work include Complement system in diseases (15 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Andrea Kocsis is often cited by papers focused on Complement system in diseases (15 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Andrea Kocsis collaborates with scholars based in Hungary, Denmark and United States. Andrea Kocsis's co-authors include Péter Gál, József Dobó, Péter Závodszky, Gábor Pál, Róbert Szász, Dávid Héja, Katalin Szilágyi, L Barna, Barbara M. Végh and Júlia Balczer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Andrea Kocsis

19 papers receiving 593 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrea Kocsis Hungary 12 467 178 120 103 88 22 603
Troels R. Kjær Denmark 13 435 0.9× 126 0.7× 60 0.5× 98 1.0× 110 1.3× 17 580
Dávid Héja Hungary 9 329 0.7× 103 0.6× 66 0.6× 102 1.0× 51 0.6× 12 466
Tamara Manuelian Germany 7 523 1.1× 254 1.4× 81 0.7× 79 0.8× 206 2.3× 7 633
László Beinrohr Hungary 9 303 0.6× 185 1.0× 123 1.0× 88 0.9× 38 0.4× 17 463
Maiken L. Henriksen Denmark 9 282 0.6× 87 0.5× 42 0.3× 95 0.9× 67 0.8× 16 412
Mina Akaiwa Japan 9 458 1.0× 48 0.3× 77 0.6× 86 0.8× 29 0.3× 9 659
SL Newman United States 8 446 1.0× 219 1.2× 56 0.5× 116 1.1× 20 0.2× 11 638
Chinami Hashimura Japan 9 526 1.1× 57 0.3× 24 0.2× 229 2.2× 20 0.2× 11 683
M. M. Tongio France 15 425 0.9× 113 0.6× 29 0.2× 74 0.7× 16 0.2× 39 617

Countries citing papers authored by Andrea Kocsis

Since Specialization
Citations

This map shows the geographic impact of Andrea Kocsis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Kocsis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Kocsis more than expected).

Fields of papers citing papers by Andrea Kocsis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Kocsis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Kocsis. The network helps show where Andrea Kocsis may publish in the future.

Co-authorship network of co-authors of Andrea Kocsis

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Kocsis. A scholar is included among the top collaborators of Andrea Kocsis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Kocsis. Andrea Kocsis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dobra, Gabriella, Edina Gyukity-Sebestyén, Tamás Várkonyi, et al.. (2025). Proteomic profiling of serum small extracellular vesicles predicts post-COVID syndrome development. Clinical Immunology. 278. 110532–110532.
2.
Bongoni, Anjan K., Bence Kiss, Jennifer L. McRae, et al.. (2025). Targeting the complement lectin pathway with a highly specific MASP-2 inhibitor protects against renal ischemia–reperfusion injury. Proceedings of the National Academy of Sciences. 122(16). e2424754122–e2424754122. 1 indexed citations
3.
Kocsis, Andrea, Edit Hirsch, Mihály Józsi, et al.. (2024). SARS-CoV-2 Nucleocapsid Protein Is Not Responsible for Over-Activation of Complement Lectin Pathway. International Journal of Molecular Sciences. 25(13). 7343–7343. 1 indexed citations
4.
Dobó, József, et al.. (2024). The Lectin Pathway of the Complement System—Activation, Regulation, Disease Connections and Interplay with Other (Proteolytic) Systems. International Journal of Molecular Sciences. 25(3). 1566–1566. 36 indexed citations
5.
Kocsis, Andrea, et al.. (2023). 149 SARS-CoV-2 nucleocapsid protein is not responsible for the activation of complement lectin pathway. Immunobiology. 228(5). 152600–152600. 3 indexed citations
6.
Héja, Dávid, Bence Kiss, Eszter Boros, et al.. (2022). Synergy of protease-binding sites within the ecotin homodimer is crucial for inhibition of MASP enzymes and for blocking lectin pathway activation. Journal of Biological Chemistry. 298(6). 101985–101985. 4 indexed citations
7.
Dobó, József, et al.. (2022). Proprotein Convertases and the Complement System. Frontiers in Immunology. 13. 958121–958121. 15 indexed citations
8.
Kocsis, Andrea, et al.. (2019). Novel MASP-2 inhibitors developed via directed evolution of human TFPI1 are potent lectin pathway inhibitors. Journal of Biological Chemistry. 294(20). 8227–8237. 12 indexed citations
9.
Boros, Eszter, József Dobó, Andrea Kocsis, et al.. (2019). Studying the structural basis for selectivity in complexes of peptide inhibitors and serine proteases of the complement system. Acta Crystallographica Section A Foundations and Advances. 75(a2). e120–e120. 1 indexed citations
10.
Dobó, József, Andrea Kocsis, & Péter Gál. (2018). Be on Target: Strategies of Targeting Alternative and Lectin Pathway Components in Complement-Mediated Diseases. Frontiers in Immunology. 9. 1851–1851. 64 indexed citations
11.
Kocsis, Andrea, László Beinrohr, József Dobó, et al.. (2018). Cutting Edge: A New Player in the Alternative Complement Pathway, MASP-1 Is Essential for LPS-Induced, but Not for Zymosan-Induced, Alternative Pathway Activation. The Journal of Immunology. 200(7). 2247–2252. 19 indexed citations
12.
Csuka, Dorottya, Lea Munthe‐Fog, Mikkel‐Ole Skjoedt, et al.. (2013). The role of ficolins and MASPs in hereditary angioedema due to C1-inhibitor deficiency. Molecular Immunology. 54(3-4). 271–277. 12 indexed citations
13.
Héja, Dávid, Andrea Kocsis, József Dobó, et al.. (2012). Revised mechanism of complement lectin-pathway activation revealing the role of serine protease MASP-1 as the exclusive activator of MASP-2. Proceedings of the National Academy of Sciences. 109(26). 10498–10503. 174 indexed citations
14.
15.
Varga, Lilian, Gábor Széplaki, Judit Laki, et al.. (2008). Depressed activation of the lectin pathway of complement in hereditary angioedema. Clinical & Experimental Immunology. 153(1). 68–74. 14 indexed citations
16.
Széplaki, Gábor, Lilian Varga, Judit Laki, et al.. (2007). Low C1-Inhibitor Levels Predict Early Restenosis After Eversion Carotid Endarterectomy. Arteriosclerosis Thrombosis and Vascular Biology. 27(12). 2756–2762. 8 indexed citations
17.
Gál, Péter, L Barna, Andrea Kocsis, & Péter Závodszky. (2006). Serine proteases of the classical and lectin pathways: Similarities and differences. Immunobiology. 212(4-5). 267–277. 46 indexed citations
18.
Gál, Péter, Veronika Harmat, Andrea Kocsis, et al.. (2005). A True Autoactivating Enzyme. Journal of Biological Chemistry. 280(39). 33435–33444. 82 indexed citations
19.
Kocsis, Andrea, et al.. (1988). The halfway house : on the road to independence. 2 indexed citations
20.
Nánási, Péter P. & Andrea Kocsis. (1951). [Pharmacology of chrysarobin].. PubMed. 124(41). 1001–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Troels R. Kjær Breakdown of academic impact, for papers by Dávid Héja Breakdown of academic impact, for papers by Tamara Manuelian Breakdown of academic impact, for papers by László Beinrohr Breakdown of academic impact, for papers by Maiken L. Henriksen Breakdown of academic impact, for papers by Mina Akaiwa Breakdown of academic impact, for papers by SL Newman Breakdown of academic impact, for papers by Chinami Hashimura Breakdown of academic impact, for papers by M. M. Tongio
Rankless by CCL
2026